Up-regulation of bone marrow stromal protein 2 (BST2) in breast cancer with bone metastasis.
about
IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damageThe role of BST-2/Tetherin in host protection and disease manifestationTargeted therapy for HM1.24 (CD317) on multiple myeloma cellsCD317 Promotes the survival of cancer cells through apoptosis-inducing factorAberrant regulation of the BST2 (Tetherin) promoter enhances cell proliferation and apoptosis evasion in high grade breast cancer cellsCounteraction of the multifunctional restriction factor tetherinThe bimodality index: a criterion for discovering and ranking bimodal signatures from cancer gene expression profiling dataBST-2/tetherin is overexpressed in mammary gland and tumor tissues in MMTV-induced mammary cancer.Interferons and their stimulated genes in the tumor microenvironmentMolecular regulation of bone marrow metastasis in prostate and breast cancerSignaling and ligand interaction of ILT7: receptor-mediated regulatory mechanisms for plasmacytoid dendritic cellsCD317/tetherin is an organiser of membrane microdomainsIdentification of alternatively translated Tetherin isoforms with differing antiviral and signaling activitiesThe interferon-inducible host factor bone marrow stromal antigen 2/tetherin restricts virion release, but is it actually a viral restriction factor?Hypermethylation of a cluster of Krüppel-type zinc finger protein genes on chromosome 19q13 in oropharyngeal squamous cell carcinoma.Glycomic analysis of membrane glycoproteins with bisecting glycosylation from ovarian cancer tissues reveals novel structures and functionsTumor antigens as proteogenomic biomarkers in invasive ductal carcinomas.Bone marrow stromal antigen 2 expressed in cancer cells promotes mammary tumor growth and metastasis.In vivo expression profile of the antiviral restriction factor and tumor-targeting antigen CD317/BST-2/HM1.24/tetherin in humans.microRNAs, Gap Junctional Intercellular Communication and Mesenchymal Stem Cells in Breast Cancer Metastasis.Bone marrow stromal antigen 2 (BST-2) DNA is demethylated in breast tumors and breast cancer cells.CD317 is over-expressed in B-cell chronic lymphocytic leukemia, but not B-cell acute lymphoblastic leukemia.Antibody-mediated enhancement of HIV-1 and HIV-2 production from BST-2/tetherin-positive cells.Overexpression of Transmembrane Protein BST2 is Associated with Poor Survival of Patients with Esophageal, Gastric, or Colorectal Cancer.Involvement of multiple myeloma cell-derived exosomes in osteoclast differentiation.Interferon-induced transmembrane protein 1 (IFITM1) overexpression enhances the aggressive phenotype of SUM149 inflammatory breast cancer cells in a signal transducer and activator of transcription 2 (STAT2)-dependent manner.2-thio-6-azauridine inhibits Vpu mediated BST-2 degradation.Potent in vitro and in vivo activity of an Fc-engineered humanized anti-HM1.24 antibody against multiple myeloma via augmented effector function.Cysteine-linked dimerization of BST-2 confers anoikis resistance to breast cancer cells by negating proapoptotic activities to promote tumor cell survival and growth.The functions of signal transducers and activators of transcriptions 1 and 3 as cytokine-inducible proteins.Plasmacytoid dendritic cells and cancer.Tumor associated regulatory dendritic cells.Dendritic cells and their role in tumor immunosurveillance.BST2 confers cisplatin resistance via NF-κB signaling in nasopharyngeal cancer.Microarray-based detection and expression analysis of new genes associated with drug resistance in ovarian cancer cell linesThe critical role of the ZNF217 oncogene in promoting breast cancer metastasis to the bone.Bone Marrow Stromal Antigen 2 Is a Novel Plasma Biomarker and Prognosticator for Colorectal Carcinoma: A Secretome-Based Verification Study.Overexpression of the transmembrane protein BST-2 induces Akt and Erk phosphorylation in bladder cancer.Induction of functional Brm protein from Brm knockout miceStructural determinant of BST-2-mediated regulation of breast cancer cell motility: a role for cytoplasmic tail tyrosine residues.
P2860
Q24337202-92B99026-2692-42C6-8F9E-F3977837DD97Q26752737-A5D62123-FF7F-4ADD-B8C7-2D66EAF25D63Q27026161-467A473A-D917-47D6-9BF9-39E2B3349597Q27468925-434BCC17-DA13-4D4A-BACE-753AFC58CE50Q28384647-A94E6768-69EC-4371-BE26-144BAC8DBD76Q28659945-DCF10F3E-976B-47C9-9F03-B97FE518F73EQ33498527-4866761B-91AF-43D2-817E-6DAD896C60E4Q33631179-945BF269-235F-43D9-975C-48B4D30158E0Q33988567-89B731AE-27C2-477E-9287-B98FC8EC3B04Q34053030-998BF308-923F-427C-AE50-3261994B4239Q34055580-DBA85B76-49C5-4244-B80F-1DD4935C04FBQ34325965-579479E7-418B-4422-AFEF-36E50CB6A5D4Q34426491-13BA4137-F4E6-484A-83BC-339E6AC3569EQ34492477-761CD441-0C9C-4E62-AEEF-3448316A0798Q34838495-F2D65D92-A95E-4B36-A103-4BA988A5E4DAQ34856178-D42B4376-2009-4BFB-BF5B-1B657FDEEEDDQ34914935-F71CBE87-0B1D-40C0-88E2-1A273C8A819DQ35021021-FF8C7BFE-0F34-4135-9AC3-EC1A472ABD93Q35170879-5803B209-8F16-4D20-A8DF-16918D7001D3Q35185340-DEC5B6B1-D558-4A54-8F68-0510268BB843Q35362935-C4AD547A-F573-43C2-A975-942F9EF4CEE9Q35405550-6CAAAFD6-6951-4F19-AE3C-E521E7EA14B1Q35531194-ADD1EB57-B0E2-481C-B98F-7605AFF3D81AQ35911232-316789D3-061B-49A0-A2F6-45007DBDF4D2Q35955440-57191528-5A57-4FBD-A3BA-70E715BA1D5FQ36599823-92AB6336-88D1-4E16-8CFF-1807262DCF15Q36646086-FB531202-19CA-461F-9066-BC6C00336C5AQ37132866-1B9CBCB9-DF73-417E-8FBF-54A6E2112324Q37745522-E68A8579-26E5-4051-8A60-05FB7E12782FQ37821935-B6E00B00-8B2B-4CBE-90F3-E2574BA06FCBQ37897799-B611D3B9-AA72-44D1-80E8-191F3FF5AF36Q37993359-CF10A13F-ED30-4B13-ABEB-33A16E3F1772Q38021625-9293435B-29B3-45CB-BE4C-AB014F2CF238Q38700288-82915376-726F-4B03-91AB-5AC32D081E6AQ38700421-CE8E1213-7E35-424F-8505-DBFD3BCA21A0Q38756694-6080B6B2-9F12-4210-9590-4D9857512A2CQ38825662-89EC3E30-4A82-4E21-97ED-9836AF0155DCQ40979460-1EC133F4-9D44-451E-9314-E1F1FA5B3E10Q41857096-38DBC2AC-CB0F-4246-8DDB-A183FC3CE946Q47155329-8AD7E3E3-E642-4414-B2BC-87E272D6573B
P2860
Up-regulation of bone marrow stromal protein 2 (BST2) in breast cancer with bone metastasis.
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Up-regulation of bone marrow s ...... t cancer with bone metastasis.
@ast
Up-regulation of bone marrow s ...... t cancer with bone metastasis.
@en
type
label
Up-regulation of bone marrow s ...... t cancer with bone metastasis.
@ast
Up-regulation of bone marrow s ...... t cancer with bone metastasis.
@en
prefLabel
Up-regulation of bone marrow s ...... t cancer with bone metastasis.
@ast
Up-regulation of bone marrow s ...... t cancer with bone metastasis.
@en
P2093
P2860
P356
P1433
P1476
Up-regulation of bone marrow s ...... t cancer with bone metastasis.
@en
P2093
P2860
P2888
P356
10.1186/1471-2407-9-102
P407
P50
P577
2009-04-01T00:00:00Z
P5875
P6179
1046919269